1 / 13

Sexual Health Market Analysis | Coherent Market Insights

Read here the market research report on u201cSexual Health Marketu201d published by CMI team.

athiranair23
Télécharger la présentation

Sexual Health Market Analysis | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market InsightS Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. Sexual Health Market Analysis (2020-2027) • Physical or psychological factors both can result into sexual dysfunction. In most cases issues with sexual health result from a combination of physical and psychological factors. It is a common health problem in both men and women. Delayed ejaculation, premature ejaculation, and inability to achieve full erection are some common sexual dysfunction symptoms in men, while symptoms such as vaginal dryness, dyspareunia are observed in women. Sexual dysfunction is categorized into four main types including desire disorders, arousal disorders, orgasm disorders, and pain disorders. These conditions can be well treated with drugs such as erectile dysfunction drugs, gender dysphoria drugs, hypoactive sexual desire disorder drugs, and premature ejaculation drugs.

  3. s • The global sexual health market is estimated to be valued at US$ 10,697.3 million in 2019, and is expected to exhibit a CAGR of 4.2% during the forecast period (2019–2027).

  4. Figure 1. Global Sexual Health Market Share (%), By Product Type, (2019 & 2027) Source: Coherent Market Insights Analysis (2019)

  5. Increasing research and development activities by key players are expected to drive growth of the market over the forecast periods • Rising involvement of major players in development of novel, and effective drug candidates for treatment of sexual dysfunction is likely to contribute to the growth of the sexual health market. For instance, in November 2019, Can-FiteBioPharma Ltd. received a patent grant in Canada, South Korea, and Israel for its drug candidate CF602, for the treatment of a sexual dysfunction. • Furthermore, increasing drug approvals from regulatory authorities and product launches are expected to drive the market growth. For instance, in November 2014, Sandoz, the generic pharmaceuticals division of Novartis, launched Vitaros, an innovative topical therapy for erectile dysfunction (ED), in Sweden.

  6. Global Sexual Health Market- Restraintss • Number of side effects such as long-lasting erection, facial flushing, visual changes, and hearing loss among others caused by using drugs for treating sexual dysfunctions may hamper consumer demand and growth of the market. Furthermore, increasing cases of undiagnosed or untreated sexual health issues may hinder the market growth.

  7. Global Sexual Health Market- Regional AnalysisS • Regional segmentation of the global sexual health market includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. • Among regions, North America is estimated to exhibit significant growth in the sexual health market owing to adoption of inorganic growth strategies by key players to launch drugs in the region. For instance, in the fourth quarter of 2015, Valeant Pharmaceuticals International, Inc. acquired Sprout Pharmaceuticals, Inc. In August 2015, Sprout Pharmaceuticals, Inc. received U.S. FDA approval for its New Drug Application (NDA) for flibanserin. Following the acquisition of Sprout Pharmaceuticals, Inc., Valeant Pharmaceuticals has introduced the flibanserin (Addyi) in the U.S. market.

  8. Figure 2: Global Sexual Health Market Share (%), By Region, (2019 & 2027) Source: Coherent Market Insights Analysis (2019)

  9. Global Sexual health Market- Competitive Landscape • Key players operating in the sexual health market include Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc., Eli Lilly & Company, Bayer AG, Vivus, Inc., Zydus Pharmaceuticals, IVFTECH APS, Merck & Co., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis International AG, Mylan Pharmaceuticals Inc., and AstraZeneca.

  10. Request sample copy here • Request PDF brochure here • Request Customization here • Talk to Analyst • Buy Now • Reference: • https://www.coherentmarketinsights.com/market-insight/sexual-health-market-3364

  11. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  12. Contact Us: • Mr. Shah • Coherent Market Insights Pvt. Ltd. • Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S. • Phone: +1-206-701-6702 • Email :sales@coherentmarketinsights.com

  13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related